Overall, TNF-α, IL-1β, and IL-6 could be valid molecular targets in light of their deregulation in autoimmune diseases and their involvement as activators of transduction cascades involving ADAM17 [121,122,123,124]. The gene discussed is IL1B; the disease is autoimmune disease.